FibroBiologics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
455 E Medical Center Blvd Ste 300, Webst...Phone Number
(281) 671-5150Website
www.fibrobiologics.comRevenue
-Stock Symbol
FBLGIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
1
About FibroBiologics
FibroBiologics is a clinical-stage biotechnology company advancing regenerative medicine by developing and commercializing fibroblast cell-based therapies aimed at treating and potentially curing chronic diseases. Its proprietary platform leverages fibroblasts and fibroblast-derived materials to create biologic treatments for conditions such as wound healing, degenerative disorders, autoimmune diseases and tissue regeneration. The company holds a large portfolio of patents and is focused on next-generation cell therapy innovation.Explore more
FibroBiologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FibroBiologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once FibroBiologics has new funding data
Product Launch: Get notified when FibroBiologics launches new products
Check if FibroBiologics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on FibroBiologics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
FibroBiologics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at FibroBiologics
Check out if FibroBiologics is spiking on competitors!
Click to see if FibroBiologics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to FibroBiologics
Compare insights from companies similar to FibroBiologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FibroBiologics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
FibroBiologics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about FibroBiologics.
FibroBiologics financials insights
Gather financial insights about FibroBiologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$100M
2023
Other Financing Round
$5M
2025
Other Financing Round
$5M
2026
Stock/Share Issuance
$3M
FibroBiologics Tech Stack
A closer look at the technologies used by FibroBiologics
Most Recent Scoops
Funding
Funding
Pain Point
FibroBiologics is currently in a Nasdaq compliance monitoring period through early next year, as the company's common stock is trading below $1, raising stockholder concerns about the risk of an additional reverse stock split or potential Nasdaq delisting.
Compliance, Stake & Stock Ownership, Finance, Risk
Person-Based
Person-Based
Person-Based
FibroBiologics News & Media
FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage
Granted claims cover Sox9-based conversion of fibroblasts into cartilage-producing cells, supporting the Company's orthopedics and degenerative disc pathways HOUSTON, Aug. 5, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage...FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
- First patients dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers - On track for interim results reporting in 2H 2026 HOUSTON, July 31, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+...FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors
Microbiologist, Retired NASA Astronaut, and Founding Director of the University of Pittsburgh Trivedi Institute for Space and Global Biomedicine Joins Board HOUSTON, July 9, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company...FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
Company expects existing supply will suffice to complete clinical trial and lead to cost savings HOUSTON, July 7, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding FibroBiologics
Sign Up For FreeTo access detailed company insights
FibroBiologics is a clinical-stage biotechnology company advancing regenerative medicine by developing and commercializing fibroblast cell-based therapies aimed at treating and potentially curing chronic diseases. Its proprietary platform leverages fibroblasts and fibroblast-derived materials to create biologic treatments for conditions such as wou... Read More
